An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder

Summary

The investigators hypothesize that EPI-743 may provide clinical benefit to children with Autism Spectrum Disorder.

Timeline

Start

2014-10-31

Primary completion

2015-11-30

Completion

2016-01-31

Outcome

Outcome not reported

Stopped (Enrollment): “This study was halted prior to enrolling.”

Drugs

Indications